The citrus bioflavonoids market is poised for significant growth, with projections indicating a valuation of ~US$ 2 billion by the end of 2030. This remarkable expansion is driven by the increasing recognition of citrus bioflavonoids' potential in managing blood sugar levels, controlling blood pressure, and reducing inflammation. Companies in the market are actively engaged in clinical trials to innovate new bioflavonoid complexes that address pre-diabetes and inflammation, highlighting the promising role of ingredients such as eriocitrin, naringin, and hesperidin.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฌ๐๐๐ซ๐๐ก ๐ซ๐๐ฉ๐จ๐ซ๐ญ @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=59439
๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ง๐ฟ๐ถ๐ฎ๐น๐ ๐ฎ๐ป๐ฑ ๐๐ป๐ป๐ผ๐๐ฎ๐๐ถ๐ผ๐ป๐: ๐ ๐ก๐ฒ๐ ๐๐ผ๐ฟ๐ถ๐๐ผ๐ป
Leading companies are investing in randomized studies on pre-diabetic patients to understand how citrus bioflavonoids can reduce insulin resistance and systolic blood pressure. This research is critical as the global prevalence of pre-diabetes continues to rise, creating a significant demand for effective management solutions. By teaming up with international medical laboratories, these companies are validating their clinical trials and gaining insights that drive innovation in the market.
๐ฃ๐ฟ๐ผ๐บ๐ถ๐๐ถ๐ป๐ด ๐ฃ๐ผ๐๐ฒ๐ป๐๐ถ๐ฎ๐น๐ ๐ถ๐ป ๐ฅ๐ฒ๐ป๐ฎ๐น ๐๐ถ๐๐ฒ๐ฎ๐๐ฒ ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐บ๐ฒ๐ป๐
Recent studies from Japan have revealed the potential of glucosyl-hesperidin (G-Hes) in managing chronic kidney disease (CKD). Given that millions of people are affected by CKD annually, and many require dialysis or kidney transplantation, bioflavonoid supplements are emerging as a recommended preventative measure by healthcare practitioners.
๐-๐๐ผ๐บ๐บ๐ฒ๐ฟ๐ฐ๐ฒ ๐ฎ๐ป๐ฑ ๐ง๐ฟ๐ฎ๐ป๐๐ฝ๐ฎ๐ฟ๐ฒ๐ป๐ฐ๐ ๐ถ๐ป ๐ฃ๐ฟ๐ผ๐ฑ๐๐ฐ๐ ๐ฅ๐ฒ๐๐ถ๐ฒ๐๐
The market is expanding at a CAGR of 6.2% during the forecast period, with bioflavonoids gaining visibility in dietary supplements and pharmaceuticals. Despite the challenge posed by the U.S. FDA's non-approval of all bioflavonoid uses, companies are educating consumers on the importance of reading product labels and seeking medical advice to avoid side effects.
E-commerce platforms are proving to be lucrative revenue streams for companies focusing on transparency in product reviews. For instance, Indian brand Purayati is aggressively marketing its vitamin C tablets enriched with citrus bioflavonoids, benefiting from positive consumer reviews and ISO-certified manufacturing standards.
๐๐น๐ถ๐ฐ๐ธ ๐ต๐ฒ๐ฟ๐ฒ ๐๐ผ ๐๐ถ๐ฒ๐ ๐๐ต๐ฒ ๐ฐ๐ผ๐บ๐ฝ๐ฟ๐ฒ๐ต๐ฒ๐ป๐๐ถ๐๐ฒ ๐ฟ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ถ๐ป ๐ณ๐๐น๐น ๐ฑ๐ฒ๐๐ฎ๐ถ๐น - https://www.transparencymarketresearch.com/citrus-bioflavonoids-market.html
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ง๐ฟ๐ฒ๐ป๐ฑ๐ ๐ฎ๐ป๐ฑ ๐ฆ๐๐ฟ๐ฎ๐๐ฒ๐ด๐ถ๐ฐ ๐๐ป๐ถ๐๐ถ๐ฎ๐๐ถ๐๐ฒ๐
Consumer interest in product safety and the origin of raw materials is driving the demand for citrus bioflavonoids. Manufacturers claim that these products are safe and allergen-free, aligning with the clean label movement that eliminates undesirable ingredients. Citrus bioflavonoids are increasingly replacing traditional clouding agents and additives in beverages and food products, opening new opportunities in the market.
Manufacturers are also leveraging online channels to launch products and offer discounts, enhancing their e-sales. Key innovations include products that boost immunity and prevent infections. Notable product launches include Yakult Honsha Co., Ltd.'s synbiotic beverage in South Korea, enriched with MicrobiomeX, and Ingredients by Nature LLC's Brewster brand, offering citrus bioflavonoids in granules and powder form.
๐๐น๐ผ๐ฏ๐ฎ๐น ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ข๐๐ฒ๐ฟ๐๐ถ๐ฒ๐ ๐ฎ๐ป๐ฑ ๐๐ฒ๐ ๐ฃ๐น๐ฎ๐๐ฒ๐ฟ๐
As of 2020, Europe leads the global citrus bioflavonoids market, holding approximately 36.7% of the market share by value. North America and East Asia follow, with significant shares. The market benefits from the rising demand across various applications, including RTE beverages, pharmaceuticals, cosmetics, and animal feed. The preference for plant-based ingredients further fuels market growth.
Key players in the global market include Ingredients by Nature LLC, Solgar Inc., NOW Foods, Organika Health Products Inc., Thermo Fisher Scientific Inc., and Yakult Honsha Co., Ltd., among others. These companies are at the forefront of innovation, expanding their product portfolios, and enhancing their presence in the market.
๐๐ฏ๐ผ๐๐ ๐จ๐ ๐ง๐ฟ๐ฎ๐ป๐๐ฝ๐ฎ๐ฟ๐ฒ๐ป๐ฐ๐ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
๐๐ผ๐ป๐๐ฎ๐ฐ๐:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453